A 0 1 0 1 O
documented 2 12 2 12 O
clinical 13 21 13 21 O
assessment 22 32 22 32 O
including 33 42 33 42 O
a 43 44 43 44 O
physical 45 53 45 53 O
assessment 54 64 54 64 O
and 65 68 65 68 O
Complete 69 77 69 77 B-clinical_variable
Blood 78 83 78 83 I-clinical_variable
Count 84 89 84 89 I-clinical_variable
( 90 91 90 91 I-clinical_variable
CBC 91 94 91 94 I-clinical_variable
) 94 95 94 95 I-clinical_variable
with 96 100 96 100 O
White 101 106 101 106 B-clinical_variable
Blood 107 112 107 112 I-clinical_variable
Cell 113 117 113 117 I-clinical_variable
Count 118 123 118 123 I-clinical_variable
( 124 125 124 125 I-clinical_variable
WBC 125 128 125 128 I-clinical_variable
) 128 129 128 129 I-clinical_variable
within 130 136 130 136 O
two 137 140 137 140 B-upper_bound
weeks 141 146 141 146 I-upper_bound
prior 147 152 147 152 I-upper_bound
to 153 155 153 155 O
enrollment 156 166 156 166 O

Age 0 3 167 170 B-age
( 4 5 171 172 O
18 5 7 172 174 B-lower_bound
years 8 13 175 180 I-lower_bound
old 14 17 181 184 O
or 18 20 185 187 O
older 21 26 188 193 O
) 26 27 193 194 O

Aphakia 0 7 195 202 B-chronic_disease
or 8 10 203 205 O
absence 11 18 206 213 O
of 19 21 214 216 O
ocular 22 28 217 223 O
lenses 29 35 224 230 O

At 0 2 231 233 O
minimum 3 10 234 241 O
five 11 15 242 246 B-lower_bound
recorded 16 24 247 255 O
FEV1 25 29 256 260 B-clinical_variable
measurements 30 42 261 273 O
obtained 43 51 274 282 O
at 52 54 283 285 O
intervals 55 64 286 295 O
of 65 67 296 298 O
at 68 70 299 301 O
least 71 76 302 307 O
two 77 80 308 311 B-lower_bound
weeks 81 86 312 317 I-lower_bound
apart 87 92 318 323 O
, 92 93 323 324 O
over 94 98 325 329 O
the 99 102 330 333 O
6 103 104 334 335 B-upper_bound
months 105 111 336 342 I-upper_bound
preceding 112 121 343 352 I-upper_bound
study 122 127 353 358 O
enrollment 128 138 359 369 O
, 138 139 369 370 O
of 140 142 371 373 O
which 143 148 374 379 O
one 149 152 380 383 O
FEV1 153 157 384 388 O
must 158 162 389 393 O
be 163 165 394 396 O
within 166 172 397 403 O
two 173 176 404 407 B-upper_bound
weeks 177 182 408 413 I-upper_bound
prior 183 188 414 419 I-upper_bound
to 189 191 420 422 O
enrollment 192 202 423 433 O

Current 0 7 434 441 O
participation 8 21 442 455 O
in 22 24 456 458 O
another 25 32 459 466 O
clinical 33 41 467 475 B-treatment
treatment 42 51 476 485 I-treatment
trial 52 57 486 491 O
with 58 62 492 496 O
an 63 65 497 499 O
investigational 66 81 500 515 B-treatment
agent 82 87 516 521 I-treatment

Diagnosis 0 9 522 531 O
of 10 12 532 534 O
new 13 16 535 538 O
BOS 17 20 539 542 B-chronic_disease
( 21 22 543 544 O
i.e. 22 26 544 548 O
, 26 27 548 549 O
new 28 31 550 553 O
BOS 32 35 554 557 O
is 36 38 558 560 O
defined 39 46 561 568 O
as 47 49 569 571 O
within 50 56 572 578 O
six 57 60 579 582 B-upper_bound
weeks 61 66 583 588 I-upper_bound
of 67 69 589 591 O
enrollment 70 80 592 602 O
) 80 81 602 603 O
based 82 87 604 609 O
on 88 90 610 612 O
laboratory 91 101 613 623 O
- 101 102 623 624 O
based 102 107 624 629 O
spirometric 108 119 630 641 B-treatment
FEV1 120 124 642 646 O
measurements 125 137 647 659 O
obtained 138 146 660 668 O
on 147 149 669 671 O
at 150 152 672 674 O
least 153 158 675 680 O
two 159 162 681 684 B-lower_bound
separate 163 171 685 693 O
occasions 172 181 694 703 O
( 182 183 704 705 O
i.e. 183 187 705 709 O
, 187 188 709 710 O
at 189 191 711 713 O
least 192 197 714 719 O
3 198 199 720 721 B-lower_bound
weeks 200 205 722 727 I-lower_bound
apart 206 211 728 733 O
) 211 212 733 734 O
that 213 217 735 739 O
have 218 222 740 744 O
declined 223 231 745 753 O
by 232 234 754 756 O
more 235 239 757 761 O
than 240 244 762 766 O
20 245 247 767 769 B-lower_bound
% 247 248 769 770 I-lower_bound
from 249 253 771 775 O
post 254 258 776 780 O
- 258 259 780 781 O
transplant 259 269 781 791 O
baseline 270 278 792 800 O
values 279 285 801 807 O
( 286 287 808 809 O
i.e. 287 291 809 813 O
, 291 292 813 814 O
using 293 298 815 820 O
ISHLT 299 304 821 826 O
definition 305 315 827 837 O
) 315 316 837 838 O

Documented 0 10 839 849 O
clinical 11 19 850 858 O
assessment 20 30 859 869 O
including 31 40 870 879 O
a 41 42 880 881 O
physical 43 51 882 890 O
assessment 52 62 891 901 O
and 63 66 902 905 O
a 67 68 906 907 O
CBC 69 72 908 911 O
with 73 77 912 916 O
WBC 78 81 917 920 O
within 82 88 921 927 O
two 89 92 928 931 B-upper_bound
weeks 93 98 932 937 I-upper_bound
prior 99 104 938 943 I-upper_bound
to 105 107 944 946 O
enrollment 108 118 947 957 O

For 0 3 958 961 O
patients 4 12 962 970 O
who 13 16 971 974 O
are 17 20 975 978 O
monitored 21 30 979 988 O
with 31 35 989 993 O
home 36 40 994 998 O
Spirometry 41 51 999 1009 B-treatment
( 52 53 1010 1011 O
subject 53 60 1011 1018 O
to 61 63 1019 1021 O
Institutional 64 77 1022 1035 O
Review 78 84 1036 1042 O
Board 85 90 1043 1048 O
( 91 92 1049 1050 O
IRB 92 95 1050 1053 O
) 95 96 1053 1054 O
approval 97 105 1055 1063 O
) 105 106 1063 1064 O

Frequent 0 8 1065 1073 O
laboratory 9 19 1074 1084 O
based 20 25 1085 1090 O
spirometry 26 36 1091 1101 O
defined 37 44 1102 1109 O
as 45 47 1110 1112 O
having 48 54 1113 1119 O
had 55 58 1120 1123 O
regular 59 66 1124 1131 O
FEV1 67 71 1132 1136 O
measurements 72 84 1137 1149 O
during 85 91 1150 1156 O
the 92 95 1157 1160 O
preceding 96 105 1161 1170 B-upper_bound
six 106 109 1171 1174 I-upper_bound
months 110 116 1175 1181 I-upper_bound
prior 117 122 1182 1187 I-upper_bound
to 123 125 1188 1190 O
diagnosis 126 135 1191 1200 O
of 136 138 1201 1203 O
new 139 142 1204 1207 O
BOS 143 146 1208 1211 B-chronic_disease
with 147 151 1212 1216 O
no 152 154 1217 1219 O
time 155 159 1220 1224 O
interval 160 168 1225 1233 O
between 169 176 1234 1241 O
FEV1 177 181 1242 1246 O
measurements 182 194 1247 1259 O
that 195 199 1260 1264 O
exceeds 200 207 1265 1272 O
8 208 209 1273 1274 B-lower_bound
weeks 210 215 1275 1280 I-lower_bound

History 0 7 1281 1288 O
of 8 10 1289 1291 O
close 11 16 1292 1297 O
FEV1 17 21 1298 1302 B-clinical_variable
monitoring 22 32 1303 1313 O
prior 33 38 1314 1319 O
to 39 41 1320 1322 O
diagnosis 42 51 1323 1332 O
of 52 54 1333 1335 O
new 55 58 1336 1339 O
BOS 59 62 1340 1343 B-chronic_disease
defined 63 70 1344 1351 O
as 71 73 1352 1354 O
having 74 80 1355 1361 O
had 81 84 1362 1365 O
either 85 91 1366 1372 O
of 92 94 1373 1375 O
the 95 98 1376 1379 O
two 99 102 1380 1383 O
monitoring 103 113 1384 1394 O
approaches 114 124 1395 1405 O

History 0 7 1406 1413 O
of 8 10 1414 1416 O
frequent 11 19 1417 1425 O
spirometry 20 30 1426 1436 O
monitoring 31 41 1437 1447 O
defined 42 49 1448 1455 O
as 50 52 1456 1458 O
having 53 59 1459 1465 O
had 60 63 1466 1469 O
regular 64 71 1470 1477 O
FEV1 72 76 1478 1482 B-clinical_variable
measurements 77 89 1483 1495 O
during 90 96 1496 1502 O
the 97 100 1503 1506 O
preceding 101 110 1507 1516 O
four 111 115 1517 1521 B-upper_bound
months 116 122 1522 1528 I-upper_bound
prior 123 128 1529 1534 I-upper_bound
to 129 131 1535 1537 O
enrollment 132 142 1538 1548 O
with 143 147 1549 1553 O
no 148 150 1554 1556 O
time 151 155 1557 1561 O
interval 156 164 1562 1570 O
between 165 172 1571 1578 O
FEV1 173 177 1579 1583 O
measurements 178 190 1584 1596 O
that 191 195 1597 1601 O
exceeds 196 203 1602 1609 O
8 204 205 1610 1611 B-lower_bound
weeks 206 211 1612 1617 I-lower_bound

Inability 0 9 1618 1627 O
to 10 12 1628 1630 O
provide 13 20 1631 1638 O
informed 21 29 1639 1647 O
consent 30 37 1648 1655 O
or 38 40 1656 1658 O
to 41 43 1659 1661 O
comply 44 50 1662 1668 O
with 51 55 1669 1673 O
study 56 61 1674 1679 B-treatment
treatments 62 72 1680 1690 I-treatment
or 73 75 1691 1693 O
assessments 76 87 1694 1705 O
( 88 89 1706 1707 O
e.g. 89 93 1707 1711 O
due 94 97 1712 1715 O
to 98 100 1716 1718 O
cognitive 101 110 1719 1728 B-chronic_disease
impairment 111 121 1729 1739 I-chronic_disease
or 122 124 1740 1742 O
geographic 125 135 1743 1753 O
distance 136 144 1754 1762 O
) 144 145 1762 1763 O

Inherent 0 8 1764 1772 O
to 9 11 1773 1775 O
the 12 15 1776 1779 O
diagnosis 16 25 1780 1789 O
of 26 28 1790 1792 O
new 29 32 1793 1796 O
BOS 33 36 1797 1800 B-chronic_disease
is 37 39 1801 1803 O
the 40 43 1804 1807 O
exclusion 44 53 1808 1817 O
of 54 56 1818 1820 O
other 57 62 1821 1826 O
potential 63 72 1827 1836 O
causes 73 79 1837 1843 O
of 80 82 1844 1846 O
allograft 83 92 1847 1856 O
dysfunction 93 104 1857 1868 O
such 105 109 1869 1873 O
as 110 112 1874 1876 O
acute 113 118 1877 1882 B-treatment
rejection 119 128 1883 1892 I-treatment
, 128 129 1892 1893 O
respiratory 130 141 1894 1905 B-chronic_disease
tract 142 147 1906 1911 I-chronic_disease
infection 148 157 1912 1921 I-chronic_disease
, 157 158 1921 1922 O
and 159 162 1923 1926 O
airway 163 169 1927 1933 B-chronic_disease
anastomotic 170 181 1934 1945 I-chronic_disease
complications 182 195 1946 1959 I-chronic_disease

Known 0 5 1960 1965 O
allergy 6 13 1966 1973 O
or 14 16 1974 1976 O
hypersensitivity 17 33 1977 1993 O
to 34 36 1994 1996 O
pharmacologic 37 50 1997 2010 B-allergy_name
agents 51 57 2011 2017 I-allergy_name
used 58 62 2018 2022 O
during 63 69 2023 2029 O
ECP 70 73 2030 2033 O

Lung 0 4 2034 2038 B-treatment
transplant 5 15 2039 2049 I-treatment
recipient 16 25 2050 2059 O
( 26 27 2060 2061 O
combined 27 35 2061 2069 O
organ 36 41 2070 2075 B-treatment
transplant 42 52 2076 2086 I-treatment
recipients 53 63 2087 2097 O
, 63 64 2097 2098 O
e.g. 65 69 2099 2103 O
heart 70 75 2104 2109 O
- 75 76 2109 2110 O
lung 76 80 2110 2114 O
or 81 83 2115 2117 O
liver 84 89 2118 2123 O
- 89 90 2123 2124 O
lung 90 94 2124 2128 O
recipients 95 105 2129 2139 O
, 105 106 2139 2140 O
are 107 110 2141 2144 O
eligible 111 119 2145 2153 O
) 119 120 2153 2154 O

Patients 0 8 2155 2163 O
whose 9 14 2164 2169 O
decline 15 22 2170 2177 O
in 23 25 2178 2180 O
lung 26 30 2181 2185 O
function 31 39 2186 2194 O
( 40 41 2195 2196 O
FEV1 41 45 2196 2200 B-clinical_variable
) 45 46 2200 2201 O
is 47 49 2202 2204 O
related 50 57 2205 2212 O
to 58 60 2213 2215 O
either 61 67 2216 2222 O
Restrictive 68 79 2223 2234 O
Chronic 80 87 2235 2242 B-chronic_disease
Lung 88 92 2243 2247 I-chronic_disease
Allograft 93 102 2248 2257 I-chronic_disease
Dysfunction 103 114 2258 2269 I-chronic_disease
( 115 116 2270 2271 I-chronic_disease
CLAD 116 120 2271 2275 I-chronic_disease
) 120 121 2275 2276 I-chronic_disease
or 122 124 2277 2279 O
other 125 130 2280 2285 O
causes 131 137 2286 2292 O
that 138 142 2293 2297 O
do 143 145 2298 2300 O
not 146 149 2301 2304 O
represent 150 159 2305 2314 O
BOS 160 163 2315 2318 B-chronic_disease
such 164 168 2319 2323 O
as 169 171 2324 2326 O
pneumonia 172 181 2327 2336 B-chronic_disease
, 181 182 2336 2337 O
heart 183 188 2338 2343 B-chronic_disease
failure 189 196 2344 2351 I-chronic_disease
, 196 197 2351 2352 O
etc 198 201 2353 2356 O

Patients 0 8 2357 2365 O
with 9 13 2366 2370 O
a 14 15 2371 2372 O
diagnosis 16 25 2373 2382 O
of 26 28 2383 2385 O
BOS 29 32 2386 2389 B-chronic_disease
using 33 38 2390 2395 O
at 39 41 2396 2398 O
least 42 47 2399 2404 O
two 48 51 2405 2408 B-lower_bound
laboratory 52 62 2409 2419 O
based 63 68 2420 2425 O
FEV1 69 73 2426 2430 B-clinical_variable
values 74 80 2431 2437 O
obtained 81 89 2438 2446 O
at 90 92 2447 2449 O
least 93 98 2450 2455 O
three 99 104 2456 2461 B-lower_bound
weeks 105 110 2462 2467 O
apart 111 116 2468 2473 O
that 117 121 2474 2478 O
are 122 125 2479 2482 O
both 126 130 2483 2487 O
at 131 133 2488 2490 O
least 134 139 2491 2496 O
20 140 142 2497 2499 B-lower_bound
% 142 143 2499 2500 I-lower_bound
lower 144 149 2501 2506 O
than 150 154 2507 2511 O
baseline 155 163 2512 2520 O
FEV1 164 168 2521 2525 O
using 169 174 2526 2531 O
the 175 178 2532 2535 O
International 179 192 2536 2549 O
Society 193 200 2550 2557 O
for 201 204 2558 2561 O
Heart 205 210 2562 2567 O
and 211 214 2568 2571 O
Lung 215 219 2572 2576 O
Transplantation 220 235 2577 2592 O
( 236 237 2593 2594 O
ISHLT 237 242 2594 2599 O
) 242 243 2599 2600 O
definition 244 254 2601 2611 O
( 255 256 2612 2613 O
The 256 259 2613 2616 O
average 260 267 2617 2624 O
of 268 270 2625 2627 O
the 271 274 2628 2631 O
two 275 278 2632 2635 O
highest 279 286 2636 2643 O
FEV1 287 291 2644 2648 O
measurements 292 304 2649 2661 O
obtained 305 313 2662 2670 O
at 314 316 2671 2673 O
least 317 322 2674 2679 O
3 323 324 2680 2681 B-lower_bound
weeks 325 330 2682 2687 I-lower_bound
apart 331 336 2688 2693 O
after 337 342 2694 2699 O
transplantation 343 358 2700 2715 B-treatment
) 358 359 2715 2716 O

Pregnancy 0 9 2717 2726 B-pregnancy
( 10 11 2727 2728 O
positive 11 19 2728 2736 B-pregnancy
pregnancy 20 29 2737 2746 I-pregnancy
test 30 34 2747 2751 O
- 35 36 2752 2753 O
a 37 38 2754 2755 O
urine 39 44 2756 2761 B-pregnancy
or 45 47 2762 2764 I-pregnancy
blood 48 53 2765 2770 I-pregnancy
pregnancy 54 63 2771 2780 I-pregnancy
test 64 68 2781 2785 O
must 69 73 2786 2790 O
be 74 76 2791 2793 O
obtained 77 85 2794 2802 O
within 86 92 2803 2809 O
2 93 94 2810 2811 B-upper_bound
weeks 95 100 2812 2817 I-upper_bound
prior 101 106 2818 2823 I-upper_bound
to 107 109 2824 2826 O
enrollment 110 120 2827 2837 O
in 121 123 2838 2840 O
women 124 129 2841 2846 B-gender
of 130 132 2847 2849 O
childbearing 133 145 2850 2862 O
potential 146 155 2863 2872 O
) 155 156 2872 2873 O

Rate 0 4 2874 2878 O
of 5 7 2879 2881 O
FEV1 8 12 2882 2886 B-clinical_variable
decline 13 20 2887 2894 O
within 21 27 2895 2901 O
the 28 31 2902 2905 O
last 32 36 2906 2910 B-upper_bound
6 37 38 2911 2912 I-upper_bound
months 39 45 2913 2919 I-upper_bound
> 46 47 2920 2921 O
300 48 51 2922 2925 B-lower_bound
mL 52 54 2926 2928 I-lower_bound
/ 54 55 2928 2929 I-lower_bound
month 55 60 2929 2934 I-lower_bound

Recent 0 6 2935 2941 O
( 7 8 2942 2943 O
i.e. 8 12 2943 2947 O
, 12 13 2947 2948 O
within 14 20 2949 2955 O
2 21 22 2956 2957 B-upper_bound
weeks 23 28 2958 2963 I-upper_bound
prior 29 34 2964 2969 I-upper_bound
to 35 37 2970 2972 O
enrollment 38 48 2973 2983 O
) 48 49 2983 2984 O
leukopenia 50 60 2985 2995 B-chronic_disease
( 61 62 2996 2997 O
white 62 67 2997 3002 B-clinical_variable
blood 68 73 3003 3008 I-clinical_variable
cell 74 78 3009 3013 I-clinical_variable
count 79 84 3014 3019 I-clinical_variable
< 85 86 3020 3021 O
3,000 87 92 3022 3027 B-upper_bound
K 93 94 3028 3029 I-upper_bound
/ 94 95 3029 3030 I-upper_bound
cumm 95 99 3030 3034 I-upper_bound
) 99 100 3034 3035 O

The 0 3 3036 3039 O
most 4 8 3040 3044 O
recent 9 15 3045 3051 O
FEV1 16 20 3052 3056 B-clinical_variable
< 21 22 3057 3058 O
900 23 26 3059 3062 B-upper_bound
mL 27 29 3063 3065 I-upper_bound

any 0 3 3066 3069 O
patient 4 11 3070 3077 O
who 12 15 3078 3081 O
at 16 18 3082 3084 O
least 19 24 3085 3090 O
one 25 28 3091 3094 B-lower_bound
year 29 33 3095 3099 I-lower_bound
after 34 39 3100 3105 I-lower_bound
transplant 40 50 3106 3116 B-treatment
is 51 53 3117 3119 O
treated 54 61 3120 3127 O
with 62 66 3128 3132 O
either 67 73 3133 3139 O
lymphocyte 74 84 3140 3150 B-treatment
depleting 85 94 3151 3160 I-treatment
therapy 95 102 3161 3168 I-treatment
or 103 105 3169 3171 O
with 106 110 3172 3176 O
an 111 113 3177 3179 O
escalated 114 123 3180 3189 O
dose 124 128 3190 3194 O
of 129 131 3195 3197 O
steroids 132 140 3198 3206 B-treatment
( 141 142 3207 3208 O
i.e. 142 146 3208 3212 O
, 146 147 3212 3213 O
prednisone 148 158 3214 3224 B-treatment
greater 159 166 3225 3232 O
than 167 171 3233 3237 O
30 172 174 3238 3240 B-lower_bound
mg 175 177 3241 3243 I-lower_bound
/ 177 178 3243 3244 O
day 178 181 3244 3247 O
) 181 182 3247 3248 O
for 183 186 3249 3252 O
more 187 191 3253 3257 O
than 192 196 3258 3262 O
one 197 200 3263 3266 B-lower_bound
month 201 206 3267 3272 I-lower_bound
for 207 210 3273 3276 O
an 211 213 3277 3279 O
acute 214 219 3280 3285 O
decline 220 227 3286 3293 O
in 228 230 3294 3296 O
lung 231 235 3297 3301 O
function 236 244 3302 3310 O
that 245 249 3311 3315 O
is 250 252 3316 3318 O
suspected 253 262 3319 3328 O
to 263 265 3329 3331 O
be 266 268 3332 3334 O
secondary 269 278 3335 3344 O
to 279 281 3345 3347 O
acute 282 287 3348 3353 B-chronic_disease
cellular 288 296 3354 3362 I-chronic_disease
rejection 297 306 3363 3372 I-chronic_disease

at 0 2 3373 3375 O
least 3 8 3376 3381 O
five 9 13 3382 3386 B-lower_bound
recorded 14 22 3387 3395 O
FEV1 23 27 3396 3400 B-clinical_variable
measurements 28 40 3401 3413 O
obtained 41 49 3414 3422 O
at 50 52 3423 3425 O
intervals 53 62 3426 3435 O
of 63 65 3436 3438 O
at 66 68 3439 3441 O
least 69 74 3442 3447 O
two 75 78 3448 3451 B-lower_bound
weeks 79 84 3452 3457 I-lower_bound
apart 85 90 3458 3463 O
, 90 91 3463 3464 O
over 92 96 3465 3469 O
the 97 100 3470 3473 O
6 101 102 3474 3475 B-lower_bound
months 103 109 3476 3482 I-lower_bound
preceding 110 119 3483 3492 I-lower_bound
study 120 125 3493 3498 O
enrollment 126 136 3499 3509 O
accompanied 137 148 3510 3521 O
by 149 151 3522 3524 O
a 152 153 3525 3526 O
statistically 154 167 3527 3540 O
significant 168 179 3541 3552 O
( 180 181 3553 3554 O
p<0.05 181 187 3554 3560 O
) 187 188 3560 3561 O
rate 189 193 3562 3566 O
of 194 196 3567 3569 O
decline 197 204 3570 3577 O
of 205 207 3578 3580 O
FEV1 208 212 3581 3585 O
that 213 217 3586 3590 O
exceeds 218 225 3591 3598 O
30 226 228 3599 3601 B-lower_bound
mL 229 231 3602 3604 I-lower_bound
/ 231 232 3604 3605 I-lower_bound
month 232 237 3605 3610 I-lower_bound

patients 0 8 3611 3619 O
with 9 13 3620 3624 O
a 14 15 3625 3626 O
specific 16 24 3627 3635 O
acute 25 30 3636 3641 O
contraindication 31 47 3642 3658 O
to 48 50 3659 3661 O
receiving 51 60 3662 3671 O
ECP 61 64 3672 3675 B-treatment
due 65 68 3676 3679 O
to 69 71 3680 3682 O
any 72 75 3683 3686 O
acute 76 81 3687 3692 O
condition 82 91 3693 3702 O
such 92 96 3703 3707 O
as 97 99 3708 3710 O
new 100 103 3711 3714 O
or 104 106 3715 3717 O
evolving 107 115 3718 3726 O
myocardial 116 126 3727 3737 B-chronic_disease
infarction 127 137 3738 3748 I-chronic_disease
or 138 140 3749 3751 O
central 141 148 3752 3759 B-chronic_disease
nervous 149 156 3760 3767 I-chronic_disease
system 157 163 3768 3774 I-chronic_disease
disorder 164 172 3775 3783 I-chronic_disease
, 172 173 3783 3784 O
hemodynamic 174 185 3785 3796 B-chronic_disease
instability 186 197 3797 3808 I-chronic_disease
or 198 200 3809 3811 O
hypovolemia 201 212 3812 3823 B-chronic_disease
, 212 213 3823 3824 O
acute 214 219 3825 3830 B-chronic_disease
bleeding 220 228 3831 3839 I-chronic_disease
, 228 229 3839 3840 O
respiratory 230 241 3841 3852 B-chronic_disease
distress 242 250 3853 3861 I-chronic_disease

patients 0 8 3862 3870 O
with 9 13 3871 3875 O
lupus 14 19 3876 3881 B-chronic_disease
erythematosus 20 33 3882 3895 I-chronic_disease
, 33 34 3895 3896 O
porphyria 35 44 3897 3906 B-chronic_disease
cutanea 45 52 3907 3914 I-chronic_disease
tarda 53 58 3915 3920 I-chronic_disease
, 58 59 3920 3921 O
erythropoietic 60 74 3922 3936 B-chronic_disease
protoporphyria 75 89 3937 3951 I-chronic_disease
, 89 90 3951 3952 O
variegate 91 100 3953 3962 B-chronic_disease
porphyria 101 110 3963 3972 I-chronic_disease
, 110 111 3972 3973 O
xeroderma 112 121 3974 3983 B-chronic_disease
pigmentosum 122 133 3984 3995 I-chronic_disease
, 133 134 3995 3996 O
albinism 135 143 3997 4005 B-chronic_disease
, 143 144 4005 4006 O
or 145 147 4007 4009 O
other 148 153 4010 4015 O
dermatologic 154 166 4016 4028 B-chronic_disease
or 167 169 4029 4031 O
ocular 170 176 4032 4038 B-chronic_disease
condition 177 186 4039 4048 I-chronic_disease
that 187 191 4049 4053 O
contraindicates 192 207 4054 4069 O
the 208 211 4070 4073 O
use 212 215 4074 4077 O
of 216 218 4078 4080 O
methoxsalen 219 230 4081 4092 B-treatment
or 231 233 4093 4095 O
markedly 234 242 4096 4104 O
enhances 243 251 4105 4113 O
photosensitivity 252 268 4114 4130 O
in 269 271 4131 4133 O
the 272 275 4134 4137 O
investigator 276 288 4138 4150 O
's 288 290 4150 4152 O
judgment 291 299 4153 4161 O

sites 0 5 4162 4167 O
are 6 9 4168 4171 O
encouraged 10 20 4172 4182 O
to 21 23 4183 4185 O
conduct 24 31 4186 4193 O
appropriate 32 43 4194 4205 O
evaluation 44 54 4206 4216 O
for 55 58 4217 4220 O
declining 59 68 4221 4230 O
allograft 69 78 4231 4240 O
function 79 87 4241 4249 O
including 88 97 4250 4259 O
bronchoscopy 98 110 4260 4272 B-treatment
with 111 115 4273 4277 I-treatment
bronchoalveolar 116 131 4278 4293 I-treatment
lavage 132 138 4294 4300 I-treatment
( 139 140 4301 4302 I-treatment
BAL 140 143 4302 4305 I-treatment
) 143 144 4305 4306 I-treatment
and 145 148 4307 4310 O
lung 149 153 4311 4315 B-treatment
biopsies 154 162 4316 4324 I-treatment
if 163 165 4325 4327 O
clinically 166 176 4328 4338 O
appropriate 177 188 4339 4350 O
to 189 191 4351 4353 O
exclude 192 199 4354 4361 O
other 200 205 4362 4367 O
potential 206 215 4368 4377 O
causes 216 222 4378 4384 O
of 223 225 4385 4387 O
allograft 226 235 4388 4397 O
dysfunction 236 247 4398 4409 O

